Variant report

Variant	nsv1044105
Chromosome Location	chr15:60318001-60354519
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:68)
CpG islands
(count:123)
Chromatin interactive
region (count:5)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:68 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr15:60317902-60318198	K562	blood:	n/a	n/a
2	ATF1	chr15:60330938-60331112	K562	blood:	n/a	n/a
3	ATF1	chr15:60327596-60327858	K562	blood:	n/a	n/a
4	ATF1	chr15:60337165-60337365	K562	blood:	n/a	n/a
5	BATF	chr15:60325729-60325922	GM12878	blood:	n/a	n/a
6	CEBPB	chr15:60337126-60337473	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr15:60352692-60352781	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr15:60337170-60337449	Hela-S3	cervix:	n/a	n/a
9	CTCF	chr15:60345400-60345550	HMEC	breast:	n/a	n/a
10	CTCF	chr15:60330500-60330650	NHEK	skin:	n/a	chr15:60330526-60330535
11	CTCF	chr15:60350480-60350630	GM12868	blood:	n/a	n/a
12	CTCF	chr15:60330400-60330550	WERI-Rb-1	eye:	n/a	chr15:60330526-60330535
13	E2F4	chr15:60345087-60345415	MCF10A-Er-Src	breast:	n/a	n/a
14	ELK1	chr15:60337126-60337330	Hela-S3	cervix:	n/a	n/a
15	FOS	chr15:60344949-60345399	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr15:60327659-60327860	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr15:60339974-60340256	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr15:60343310-60343625	MCF10A-Er-Src	breast:	n/a	n/a
19	FOS	chr15:60318899-60319072	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr15:60318882-60319044	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr15:60345069-60345352	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr15:60339971-60340252	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr15:60344948-60345395	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr15:60340010-60340211	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr15:60318912-60318985	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr15:60339996-60340276	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr15:60345027-60345325	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr15:60343317-60343649	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr15:60330943-60331143	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr15:60318883-60319021	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr15:60343315-60343641	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr15:60337297-60337359	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr15:60343373-60343640	MCF10A-Er-Src	breast:	n/a	n/a
34	FOXA1	chr15:60327563-60327941	HepG2	liver:	n/a	chr15:60327745-60327760
35	FOXA1	chr15:60327619-60327751	T-47D	breast:	n/a	n/a
36	FOXA2	chr15:60327552-60327967	A549	lung:	n/a	n/a
37	JUND	chr15:60337178-60337474	H1-hESC	embryonic stem cell:	n/a	n/a
38	KAP1	chr15:60353971-60354348	U2OS	brain:	n/a	n/a
39	KAP1	chr15:60353866-60354466	HEK293	kidney:	n/a	n/a
40	KAP1	chr15:60341988-60342998	K562	blood:	n/a	n/a
41	MAFF	chr15:60336099-60336279	K562	blood:	n/a	n/a
42	MAFF	chr15:60335987-60336262	HepG2	liver:	n/a	n/a
43	MAFK	chr15:60335970-60336303	HepG2	liver:	n/a	n/a
44	MAFK	chr15:60336117-60336187	Hela-S3	cervix:	n/a	n/a
45	MAFK	chr15:60336064-60336242	IMR90	lung:	n/a	n/a
46	MAFK	chr15:60335963-60336307	HepG2	liver:	n/a	n/a
47	MAX	chr15:60336788-60336807	NB4	blood:	n/a	n/a
48	MYC	chr15:60345057-60345254	MCF10A-Er-Src	breast:	n/a	n/a
49	MYC	chr15:60348471-60348492	MCF-7	breast:	n/a	n/a
50	MYC	chr15:60337076-60337475	NB4	blood:	n/a	chr15:60337304-60337313

(count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:60331745-60331795	PANC-1	pancreas:	n/a
2	chr15:60331745-60331795	PANC-1	pancreas:	n/a
3	chr15:60331745-60331795	NHDF-neo	bronchial:	n/a
4	chr15:60337250-60337300	CMK	blood:	n/a
5	chr15:60337250-60337300	AoSMC	blood vessel:	n/a
6	chr15:60331745-60331795	BJ	skin:	n/a
7	chr15:60337250-60337300	HEK293	kidney:	embryo
8	chr15:60337250-60337300	GM19239	blood:	n/a
9	chr15:60337250-60337300	HPAEpiC	pulmonary alveolar:	n/a
10	chr15:60331745-60331795	HRCEpiC	kidney:	n/a
11	chr15:60331745-60331795	HRE	kidney:	n/a
12	chr15:60331745-60331795	HIPEpiC	eye:	n/a
13	chr15:60337250-60337300	Hela-S3	cervix:	n/a
14	chr15:60337250-60337300	T-47D	breast:	n/a
15	chr15:60337250-60337300	MCF-7	breast:	n/a
16	chr15:60331745-60331795	Jurkat	blood:	n/a
17	chr15:60337250-60337300	Caco-2	colon:	n/a
18	chr15:60331745-60331795	MCF10A-Er-Src	breast:	n/a
19	chr15:60337250-60337300	HAEpiC	amniotic membrane:	n/a
20	chr15:60337250-60337300	SKMC	muscle:	n/a
21	chr15:60337250-60337300	HUVEC	blood vessel:	n/a
22	chr15:60337250-60337300	NT2-D1	testis:	n/a
23	chr15:60331745-60331795	AoSMC	blood vessel:	n/a
24	chr15:60331745-60331795	HCF	heart:	n/a
25	chr15:60331745-60331795	T-47D	breast:	n/a
26	chr15:60331745-60331795	GM12891	blood:	n/a
27	chr15:60331745-60331795	IMR90	lung:	fetal
28	chr15:60331745-60331795	BE2_C	brain:	n/a
29	chr15:60337250-60337300	HEEpiC	esophagus:	n/a
30	chr15:60331745-60331795	ECC-1	luminal epithelium:	n/a
31	chr15:60337250-60337300	HepG2	liver:	n/a
32	chr15:60337250-60337300	SAEC	small airway:	n/a
33	chr15:60331745-60331795	NH-A	brain:	n/a
34	chr15:60337250-60337300	NB4	blood:	n/a
35	chr15:60331745-60331795	PrEC	prostate:	n/a
36	chr15:60331745-60331795	ProgFib	skin:	n/a
37	chr15:60337250-60337300	LNCaP	prostate:	n/a
38	chr15:60331745-60331795	SAEC	small airway:	n/a
39	chr15:60337250-60337300	Hepatocyte	liver:	n/a
40	chr15:60331745-60331795	SKMC	muscle:	n/a
41	chr15:60331745-60331795	GM19239	blood:	n/a
42	chr15:60337250-60337300	HCT-116	colon:	n/a
43	chr15:60337250-60337300	SK-N-SH_RA	brain:	n/a
44	chr15:60331745-60331795	HL-60	blood:	n/a
45	chr15:60337250-60337300	NHDF-neo	bronchial:	n/a
46	chr15:60337250-60337300	GM12892	blood:	n/a
47	chr15:60337250-60337300	ProgFib	skin:	n/a
48	chr15:60331745-60331795	Hela-S3	cervix:	n/a
49	chr15:60331745-60331795	CMK	blood:	n/a
50	chr15:60337250-60337300	HCPEpiC	choroid plexus:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:60336258..60337887-chr15:60346739..60349719,2	MCF-7	breast:
2	chr15:60336258..60337887-chr15:60346739..60349719,2	MCF-7	breast:
3	chr15:60321662..60323517-chr15:60325565..60328073,2	K562	blood:
4	chr15:60352349..60354730-chr15:60356630..60358412,2	K562	blood:
5	chr15:60321662..60323517-chr15:60325565..60328073,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FOXB1-6	chr15:60328329-60328441	NONHSAT044193
2	lnc-FOXB1-6	chr15:60317955-60318108	NONHSAT044192
3	lnc-ANXA2-3	chr15:60345403-60346291	NONHSAT044194
4	lnc-FOXB1-6	chr15:60333811-60334098	NONHSAT044193
5	lnc-FOXB1-6	chr15:60328309-60328428	NONHSAT044192
6	lnc-FOXB1-6	chr15:60353847-60353929	NONHSAT044192

No data

Variant related genes	Relation type
FOXB1	TF binding region
MESTP2	TF binding region
FOXB1	CpG island
MESTP2	CpG island

Extended variants
information (count: 1419 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:1419 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375638776	chr15:60318041-60318042	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
2	rs139574589	chr15:60318046-60318047	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
3	rs144302489	chr15:60318066-60318067	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs189702152	chr15:60318070-60318071	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
5	rs182316178	chr15:60318087-60318088	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs571728076	chr15:60318092-60318093	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
7	rs61628415	chr15:60318119-60318120	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs4775233	chr15:60318124-60318125	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs569320053	chr15:60318134-60318135	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs151026977	chr15:60318220-60318221	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs537467568	chr15:60318278-60318279	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs556905299	chr15:60318323-60318324	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs139702203	chr15:60318327-60318328	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs541953767	chr15:60318355-60318356	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs78186806	chr15:60318443-60318444	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs377033780	chr15:60318444-60318445	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs397808495	chr15:60318445-60318446	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs7169634	chr15:60318541-60318542	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs534600573	chr15:60318583-60318584	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs113681057	chr15:60318584-60318585	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs187065980	chr15:60318626-60318627	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs577752170	chr15:60318628-60318629	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs149778761	chr15:60318657-60318658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190311386	chr15:60318755-60318756	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs559568688	chr15:60318822-60318823	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs575730276	chr15:60318835-60318836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs55643166	chr15:60318839-60318840	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs540805130	chr15:60318845-60318846	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs561109930	chr15:60318847-60318848	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs7171686	chr15:60318863-60318864	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs540568119	chr15:60318865-60318866	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs565516844	chr15:60318869-60318870	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs532527619	chr15:60318897-60318898	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs551065742	chr15:60318909-60318910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs376664863	chr15:60318929-60318930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs529727188	chr15:60318943-60318944	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs183600811	chr15:60318951-60318952	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs548999771	chr15:60318972-60318973	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs113463648	chr15:60318975-60318976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs28752124	chr15:60319044-60319045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs28727953	chr15:60319045-60319046	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs77711446	chr15:60319046-60319047	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs398027535	chr15:60319052-60319053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs141899968	chr15:60319061-60319062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs369357080	chr15:60319076-60319077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs75767249	chr15:60319082-60319083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs546536281	chr15:60319093-60319094	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs11071497	chr15:60319128-60319129	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs538808853	chr15:60319129-60319130	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs147719985	chr15:60319189-60319190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Mental retardation	17124404	CNVD
Gastrointestinal stromal cancer	20877625	CNVD

Chromatin state (count:151 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:60316400-60318400	Enhancers	iPS-18 Cell Line	embryonic stem cell
2	chr15:60316400-60319200	Enhancers	Ovary	ovary
3	chr15:60316600-60318600	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr15:60316800-60318200	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr15:60317200-60318200	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr15:60317200-60318400	Enhancers	ES-I3 Cell Line	embryonic stem cell
7	chr15:60317200-60318400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr15:60317200-60318400	Enhancers	HUES6 Cell Line	embryonic stem cell
9	chr15:60317200-60318600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr15:60317400-60318200	Enhancers	H1 Cell Line	embryonic stem cell
11	chr15:60317400-60318200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr15:60317600-60318400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr15:60317800-60324200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
14	chr15:60318000-60318200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr15:60318000-60318200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr15:60318000-60318200	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr15:60318000-60319200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr15:60318200-60318600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
19	chr15:60318400-60319600	Weak transcription	HUES6 Cell Line	embryonic stem cell
20	chr15:60318600-60319000	Enhancers	Primary hematopoietic stem cells short term culture	blood
21	chr15:60319600-60319800	Enhancers	HUES6 Cell Line	embryonic stem cell
22	chr15:60325400-60325600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr15:60329000-60329200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr15:60329000-60329200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr15:60329200-60329800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
26	chr15:60329200-60329800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr15:60329200-60330000	Enhancers	iPS-15b Cell Line	embryonic stem cell
28	chr15:60329200-60331200	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr15:60329200-60332200	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr15:60329800-60330600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr15:60329800-60330600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr15:60329800-60331000	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr15:60329800-60331000	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr15:60329800-60332200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr15:60330000-60330200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
36	chr15:60330000-60330200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
37	chr15:60330000-60330200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr15:60330000-60330600	Enhancers	H1 Cell Line	embryonic stem cell
39	chr15:60330000-60330800	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr15:60330000-60330800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr15:60330000-60330800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr15:60330000-60330800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr15:60330000-60331000	Enhancers	NHEK	skin
44	chr15:60330200-60330400	Enhancers	H9 Cell Line	embryonic stem cell
45	chr15:60330200-60330400	Enhancers	iPS-15b Cell Line	embryonic stem cell
46	chr15:60330200-60330600	Enhancers	Lung	lung
47	chr15:60330200-60331200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr15:60330200-60334400	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr15:60330400-60330600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
50	chr15:60330400-60331200	Weak transcription	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links